Company page
Boundless Bio, Inc.
Boundless Bio, Inc. is a public company traded under the ticker BOLD in the American market. The company has a market capitalization of approximately $32.1 million. Boundless Bio focuses on developing innovative therapies for cancer treatment.
- Ticker
- BOLD:NASDAQ
- Asset type
- Stock
- Market cap
- $32.1M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD